Abstract
This Clinical Practice Update clarifies guidance on paternal genotyping and provides new recommendations on the role of noninvasive fetal red blood cell antigen genotyping using cell-free DNA (cfDNA). This document updates Practice Bulletin No. 192, Management of Alloimmunization in Pregnancy (Obstet Gynecol 2018;131:e82–90).
Publisher
Ovid Technologies (Wolters Kluwer Health)